Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-036256
Filing Date
2024-02-14
Accepted
2024-02-14 16:17:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G d767902dsc13g.htm SC 13G 39709
2 EX-99.1 d767902dex991.htm EX-99.1 5043
  Complete submission text file 0001193125-24-036256.txt   46180
Mailing Address 11080 CIRCLEPOINT RD., STE, 200 WESTMINSTER CO 80020
Business Address
BERNS PAUL L (Filed by) CIK: 0001202769 (see all company filings)

Type: SC 13G

Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Subject) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94162 | Film No.: 24638580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)